Literature DB >> 24712411

Guidelines for the first line management of classical Hodgkin lymphoma.

George A Follows1, Kirit M Ardeshna, Sally F Barrington, Dominic J Culligan, Peter J Hoskin, David Linch, Shalal Sadullah, Michael V Williams, Jennifer Z Wimperis.   

Abstract

Entities:  

Keywords:  Hodgkin; Hodgkin lymphoma; chemotherapy; radiotherapy; treatment

Mesh：

Year:  2014        PMID： 24712411     DOI： 10.1111/bjh.12878

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  18 in total

Review 1.  How I treat advanced Hodgkin lymphoma - a global view.

Authors:  Peter Hokland; Mansi Shah; Kevin David; Andrew Evens; Rebecca Auer; Rifca Ledieu; Stefanie Kreissl; Paul J Bröckelmann; Peter Borchmann; Anu Korula; Vikram Mathews; Weerapat Owattanapanich; Judith Trotman
Journal:  Br J Haematol       Date:  2020-06-19       Impact factor: 6.998

Review 2.  FDG PET/CT imaging as a biomarker in lymphoma.

Authors:  Michel Meignan; Emmanuel Itti; Andrea Gallamini; Anas Younes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

3.  PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues.

Authors:  Oke Gerke; Karen Ehlers; Edith Motschall; Poul Flemming Høilund-Carlsen; Werner Vach
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

4.  Role of CT Density in PET/CT-Based Assessment of Lymphoma.

Authors:  Paul Flechsig; Christina Walker; Clemens Kratochwil; Laila König; Andrei Iagura; Jan Moltz; Tim Holland-Letz; Hans-Ulrich Kauczor; Uwe Haberkorn; Frederik L Giesel
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

5.  Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience.

Authors:  J Gayoso; P Balsalobre; M J Pascual; C Castilla-Llorente; L López-Corral; M Kwon; D Serrano; J L Piñana; P Herrera; C Ferrá; C Pascual; I Heras; P Montesinos; A Zabalza; L Bento; A Figuera; I Buño; J L Díez-Martín
Journal:  Bone Marrow Transplant       Date:  2016-05-09       Impact factor: 5.483

Review 6.  Hodgkin Lymphoma: the Changing Role of Radiation Therapy in Early-Stage Disease—the Role of Functional Imaging.

Authors:  David J Iberri; Richard T Hoppe; Ranjana H Advani
Journal:  Curr Treat Options Oncol       Date:  2015-09

7.  Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD.

Authors:  Paul Flechsig; Olena Hural; Michael Kreuter; Martin Eichhorn; Gudula HEUßEL; Christos Sachpekidis; Hans-Ulrich Kauczor; Uwe Haberkorn; Claus Peter Heussel; Monika Eichinger
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

8.  Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma.

Authors:  A K Gopal; M A Fanale; C H Moskowitz; A R Shustov; S Mitra; W Ye; A Younes; A J Moskowitz
Journal:  Ann Oncol       Date:  2017-05-01       Impact factor: 32.976

9.  Hodgkin disease-an ever-evolving therapy.

Authors:  Eldad J Dann
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

10.  Applicability of protocols from high-income countries in a resource limited setting; real world data of histopathology, clinical features and long-term outcome of Hodgkin Lymphoma in Sri Lanka.

Authors:  Saman Hewamana; Lakmali Kandabadage; Thurairajah Skandarajah; Natasha Peiris; Sobitha Abeyaratne; Gehan Arseculeratne; Eranga Perera; Mahesh Harischandra; Ananda Wijewickrama; Gnani Somasundaram; Vadivelu Srinivasan; Surjit Somiah; Priyankara Jayawardena; Rohini Wadanamby; Geethani Galagoda; Chathuri Jayasinghe; Chandu De Silva; Sanjeewa Munasinghe; Bandula Wijesiriwardena; Jayantha Balawardena
Journal:  EClinicalMedicine       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.